The Promise and Perils of Precision Oncology with Eric Marsden, ND
Worth 1 CE
In this session we will discuss the current state of the science around personalized cancer care (PCC). Incredible advances are being made in the areas of Next Generation Sequencing (NGS) of tumors and circulating tumor cells (CTCs), Tumor xenograft assays, isolation, analysis of circulating tumor DNA, and even pharmacogenomics. We will explore the current state of evidence for the role PCC can play in surveillance, therapy selection and monitoring, and determining prognosis with particular emphasis on how it might impact naturopathic interventions. Finally, we will muse about what is on the horizon for personalized medicine.
Learning Objectives
Understand the various methods of assessment technologies that are a part of the umbrella or personalized medicine and how they can impact naturopathic cancer care
Understand the current approved applications for these assessments
Understand the evidence behind non-approved indications for these assessments
Be able to determine how and when to utilize these tools in your clinical practice currently
Worth 1 CE
In this session we will discuss the current state of the science around personalized cancer care (PCC). Incredible advances are being made in the areas of Next Generation Sequencing (NGS) of tumors and circulating tumor cells (CTCs), Tumor xenograft assays, isolation, analysis of circulating tumor DNA, and even pharmacogenomics. We will explore the current state of evidence for the role PCC can play in surveillance, therapy selection and monitoring, and determining prognosis with particular emphasis on how it might impact naturopathic interventions. Finally, we will muse about what is on the horizon for personalized medicine.
Learning Objectives
Understand the various methods of assessment technologies that are a part of the umbrella or personalized medicine and how they can impact naturopathic cancer care
Understand the current approved applications for these assessments
Understand the evidence behind non-approved indications for these assessments
Be able to determine how and when to utilize these tools in your clinical practice currently
Worth 1 CE
In this session we will discuss the current state of the science around personalized cancer care (PCC). Incredible advances are being made in the areas of Next Generation Sequencing (NGS) of tumors and circulating tumor cells (CTCs), Tumor xenograft assays, isolation, analysis of circulating tumor DNA, and even pharmacogenomics. We will explore the current state of evidence for the role PCC can play in surveillance, therapy selection and monitoring, and determining prognosis with particular emphasis on how it might impact naturopathic interventions. Finally, we will muse about what is on the horizon for personalized medicine.
Learning Objectives
Understand the various methods of assessment technologies that are a part of the umbrella or personalized medicine and how they can impact naturopathic cancer care
Understand the current approved applications for these assessments
Understand the evidence behind non-approved indications for these assessments
Be able to determine how and when to utilize these tools in your clinical practice currently